Screener
OptimizeRx OPRX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: OptimizeRx’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001448431-26-000016
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $(703) | $1,532 | $(1,198) | $(667) |
| Other comprehensive income (loss), net of tax: | ||||
| Foreign currency translation adjustment | 11 | — | 11 | — |
| Comprehensive income (loss) | $(692) | $1,532 | $(1,187) | $(667) |
| Weighted average number of shares outstanding – basic | 18,785,596 | 18,510,834 | 18,773,638 | 18,490,931 |
| Weighted average number of shares outstanding – diluted | 18,785,596 | 19,015,496 | 18,773,638 | 18,490,931 |
| Income (loss) per share – basic | $(0.04) | $0.08 | $(0.06) | $(0.04) |
| Income (loss) per share – diluted | $(0.04) | $0.08 | $(0.06) | $(0.04) |
Item 1. Financial Statements
FAQ
- What is OptimizeRx's EPS (diluted)?
- OptimizeRx (OPRX) reported EPS (diluted) of -$0.04 in Q2 2026.
- How has OptimizeRx's EPS (diluted) changed year-over-year?
- OptimizeRx's EPS (diluted) decreased by 150.0% year-over-year, from $0.08 to -$0.04.
- What is the long-term trend for OptimizeRx's EPS (diluted)?
- Over 4 years (2021 to 2025), OptimizeRx's EPS (diluted) has grown at a 125.8% compound annual growth rate (CAGR), from $0.01 to $0.26.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about OptimizeRx's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude